Meglumine antimoniate

Meglumine antimoniate
Systematic (IUPAC) name
Hydroxy-dioxostiborane; (2R,3R,4R,5S)-6-methylaminohexane-1,2,3,4,5-pentol
Clinical data
AHFS/Drugs.com Micromedex Detailed Consumer Information
Pregnancy cat.  ?
Legal status  ?
Identifiers
CAS number 133-51-7 N
ATC code P01CB01 QP51AB01
PubChem CID 64953
ChemSpider 58479 Y
ChEMBL CHEMBL239129 Y
Chemical data
Formula Variable
Mol. mass Variable
SMILES eMolecules & PubChem
 N(what is this?)  (verify)

Meglumine antimoniate (or meglumine antimonate) is a medicine used for treating leishmaniasis. It is manufactured by Aventis and sold as Glucantime in France, and Glucantim in Italy. It belongs to a group of compounds known as the pentavalent antimonials. It is administered by intramuscular injection.

See also